Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?

about

Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care.

P2860

Q37282476-C0E62E43-9632-4179-AB10-5AF2D04AAA31

P2860

Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?

Item

http://www.wikidata.org/entity/Q42293563

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Are we exposing patients with ...... to unnecessary investigations?

@en

Are we exposing patients with ...... to unnecessary investigations?

@nl

type

Item

label

Are we exposing patients with ...... to unnecessary investigations?

@en

Are we exposing patients with ...... to unnecessary investigations?

@nl

prefLabel

Are we exposing patients with ...... to unnecessary investigations?

@en

Are we exposing patients with ...... to unnecessary investigations?

@nl

P1476

Are we exposing patients with ...... to unnecessary investigations?

@en

P2093

D R Gaya

http://www.w3.org/2001/XMLSchema#string

F Thomson

http://www.w3.org/2001/XMLSchema#string

J P Seenan

http://www.w3.org/2001/XMLSchema#string

K Rankin

http://www.w3.org/2001/XMLSchema#string

K Smith

http://www.w3.org/2001/XMLSchema#string

P2860

A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence

Small bowel Crohn's disease: MR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease

P304

156-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/FLGASTRO-2014-100467

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28839805

http://www.w3.org/2001/XMLSchema#string

P921

Aka

P932

5369576

http://www.w3.org/2001/XMLSchema#string

Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?

about

P2860

P2860

Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932